Global Epinephrine Market Size, Share and Trends Analysis, By Product Type (Auto-Injector, Prefilled Syringes, Ampoules and Vials), By Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders and Others), Forecast (2022-2028)

The global epinephrine market is anticipated to grow at a CAGR of nearly 7.0% during the forecast period (2022-2028). Epinephrine also called as adrenaline is a hormone and neurotransmitter produced by the adrenal glands. Epinephrine supports to reverse the effects of anaphylaxis and it is used as the first line of treatment. Auto-injectors are commonly used by individuals suffering from anaphylaxis, as it can be administered by non- medical person. Epinephrine is available in different doses and concentrations for delivery by different routes and for different indications, including respiratory disorders.

The market is segmented based on the product type and application. Based on the product type, the market is sub-segmented into auto injector, prefilled syringes, and ampoules and vials. An auto injector is a medical device that is designed to deliver a dose of a particular drug. A pre-filled syringe is a disposable syringe that is supplied already loaded with the substance to be injected. A vial is a small glass or plastic vessel or bottle, often used to store medication as liquids, powders or capsules. An ampoule is a small sealed vial which is used to contain and preserve a sample, usually a solid or liquid. For instance, in July 2019, Sandoz, a Novartis AG division, has launched its generic pre-filled Symjepi epinephrine shots.

Some major players in the market include Mylan N.V., Pfizer, Inc., and Teva Pharmaceuticals Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, Alerje Inc., which is a food allergy management company based in Detroit, introduced a smartphone case equipped with auto-injector that rapidly releases epinephrine during severe allergic reactions. It will also automatically alter the patients’ support circle through Alerje smartphone app when a dose is discharged from the case. Additionally, in April 2020, Amphastar Pharmaceuticals Inc, made an announcement regarding winning of an FDA approved for the new drug application of its epinephrine injection, USP 30mg/30mL (1mg/mL), available in multiple dose vials.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By  Product Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Mylan N.V., Pfizer, Inc., and Teva Pharmaceuticals Industries Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Epinephrine Market Report by Segment

By Product Type

• Auto- Injector
• Prefilled Syringes
• Ampoules
• Vials

By Application

• Anaphylaxis,
• Cardiac Arrest,
• Superficial Bleeding,
• Respiratory Disorders
• Others

Global Epinephrine Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa